Review



t philips ingenia mri scanner  (Philips Healthcare)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Philips Healthcare t philips ingenia mri scanner
    T Philips Ingenia Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/3+philips+scanner+t/pmc13276324-117-6-7
    Average 86 stars, based on 1 article reviews
    t philips ingenia mri scanner - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    Diagnostic Assay:

    Article Title: Hyperintense acute reperfusion marker (HARM) and thrombus analysis in acute ischemic stroke
    Article Snippet: MRI was performed using 1.5-T scanners (Ingenia, Philips Healthcare, Best, the Netherlands, or Magnetom Aera, Siemens, Munich, Germany).

    Article Title: Partitioned Internal Auditory Canal: Association With Cochlear Aperture Anomalies.
    Article Snippet: Objective: To investigate the association between partitioned internal auditory canal (IAC) and other inner ear abnormalities.. Methods: The temporal bone computed tomography (CT) and magnetic resonance imaging (MRI) findings of ears with partitioned IAC were retrospectively analyzed.. The IAC was considered narrow if its midportion diameter < 2 mm.

    Article Title: Application of ultrasound-guided percutaneous catheter drainage in the treatment of tuberculous psoas abscesses
    Article Snippet: Ultrasound (Philips iU-Elite ultrasonic diagnostic apparatus (Washington, USA) with the C5-1 broadband convex array probe (frequency 1–5 MHz)), CT (Philips Brilliance iCT (Ohio, USA)), and MRI (Philips Achieva (Ohio, USA) 3.0 T) were performed to assess the condition, and personalized management plans were developed based on the results and patient preferences.

    Article Title: TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis.
    Article Snippet: At WMIC, MRI was performed with 1.5T Achieva (HC, n = 25) or 3T Achieva (HC, n = 14) scanner (Philips, Best, the Netherlands).

    Article Title: Role of Whole-Body Magnetic Resonance Imaging in Detecting Metastasis in Patients With Known Cancer
    Article Snippet: WB-MRI was subsequently performed using a 1.5-T Philips Achieva DS MR system (Philips Healthcare, Brazil).

    Article Title: Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis.
    Article Snippet: Briefly, MRI were performed at a field strength of 1.5 Tesla (Ingenia; Philips Healthcare, Best, the Netherlands).

    Magnetic Resonance Imaging:

    Article Title: Hyperintense acute reperfusion marker (HARM) and thrombus analysis in acute ischemic stroke
    Article Snippet: MRI was performed using 1.5-T scanners (Ingenia, Philips Healthcare, Best, the Netherlands, or Magnetom Aera, Siemens, Munich, Germany).

    Article Title: Partitioned Internal Auditory Canal: Association With Cochlear Aperture Anomalies.
    Article Snippet: Objective: To investigate the association between partitioned internal auditory canal (IAC) and other inner ear abnormalities.. Methods: The temporal bone computed tomography (CT) and magnetic resonance imaging (MRI) findings of ears with partitioned IAC were retrospectively analyzed.. The IAC was considered narrow if its midportion diameter < 2 mm.

    Article Title: Application of ultrasound-guided percutaneous catheter drainage in the treatment of tuberculous psoas abscesses
    Article Snippet: Ultrasound (Philips iU-Elite ultrasonic diagnostic apparatus (Washington, USA) with the C5-1 broadband convex array probe (frequency 1–5 MHz)), CT (Philips Brilliance iCT (Ohio, USA)), and MRI (Philips Achieva (Ohio, USA) 3.0 T) were performed to assess the condition, and personalized management plans were developed based on the results and patient preferences.

    Article Title: TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis.
    Article Snippet: At WMIC, MRI was performed with 1.5T Achieva (HC, n = 25) or 3T Achieva (HC, n = 14) scanner (Philips, Best, the Netherlands).

    Article Title: Role of Whole-Body Magnetic Resonance Imaging in Detecting Metastasis in Patients With Known Cancer
    Article Snippet: WB-MRI was subsequently performed using a 1.5-T Philips Achieva DS MR system (Philips Healthcare, Brazil).

    Article Title: Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis.
    Article Snippet: Briefly, MRI were performed at a field strength of 1.5 Tesla (Ingenia; Philips Healthcare, Best, the Netherlands).



    Similar Products

    t whole body mri system  (Siemens Healthineers)
    86
    Siemens Healthineers t whole body mri system
    T Whole Body Mri System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/body+mri+system+t+whole/pmc13200137-153-8-13
    Average 86 stars, based on 1 article reviews
    t whole body mri system - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    mri compatible fiber optic response unit  (Psychology Software Tools)
    94
    Psychology Software Tools mri compatible fiber optic response unit
    Mri Compatible Fiber Optic Response Unit, supplied by Psychology Software Tools, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/Celeritas/pm42805440-59-5-10
    Average 94 stars, based on 1 article reviews
    mri compatible fiber optic response unit - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    t philips ingenia mri scanner  (Philips Healthcare)
    86
    Philips Healthcare t philips ingenia mri scanner
    T Philips Ingenia Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/3+philips+scanner+t/pmc13276324-117-6-7
    Average 86 stars, based on 1 article reviews
    t philips ingenia mri scanner - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    t mri scanner  (Philips Healthcare)
    86
    Philips Healthcare t mri scanner
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    T Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/mri+scanner+t/pmc13276516-99-11-14
    Average 86 stars, based on 1 article reviews
    t mri scanner - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    mri scanner details  (Siemens Healthineers)
    86
    Siemens Healthineers mri scanner details
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Mri Scanner Details, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/mri+scanner+t/pmc13196352-31-0-11
    Average 86 stars, based on 1 article reviews
    mri scanner details - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    mri images  (Philips Healthcare)
    86
    Philips Healthcare mri images
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Mri Images, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/images+mri/pmc13264218-71-12-16
    Average 86 stars, based on 1 article reviews
    mri images - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    electromyography (emg) research  (MyoLearn)
    99
    MyoLearn electromyography (emg) research
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Electromyography (Emg) Research, supplied by MyoLearn, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/Electromyography+(EMG)+Research/custom%40emg%4042466981
    Average 99 stars, based on 1 article reviews
    electromyography (emg) research - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    3 0 t magnetic resonance imaging mri  (Siemens Healthineers)
    86
    Siemens Healthineers 3 0 t magnetic resonance imaging mri
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    3 0 T Magnetic Resonance Imaging Mri, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/imaging+magnetic+resonance/pmc13266175-41-23-29
    Average 86 stars, based on 1 article reviews
    3 0 t magnetic resonance imaging mri - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    hyperion  (Psychology Software Tools)
    94
    Psychology Software Tools hyperion
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Hyperion, supplied by Psychology Software Tools, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/Hyperion/custom%40pst-101891%4042342996
    Average 94 stars, based on 1 article reviews
    hyperion - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    mri  (Siemens Healthineers)
    86
    Siemens Healthineers mri
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Mri, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mri/mri/pmc08633812-25-7-8
    Average 86 stars, based on 1 article reviews
    mri - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic MRI), demonstrating patient-specific changes in T2/FLAIR region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: Clinical and Translational Radiation Oncology

    Article Title: Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator

    doi: 10.1016/j.ctro.2026.101200

    Figure Lengend Snippet: Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic MRI), demonstrating patient-specific changes in T2/FLAIR region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: For radiotherapy planning, all patients underwent MR simulation on a 1.5 T MRI scanner (Philips Ingenia) with gadolinium-enhanced T1-weighted, T2-weighted, diffusion-weight imaging (DWI), and fluid-attenuated inversion recovery (FLAIR) volumetric sequences.

    Techniques: Diagnostic Assay, Migration, Methylation

    Longitudinal relative change in MR-Linac T2/FLAIR region of interest (ROI) volume from baseline (V rel , %) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines represent individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Journal: Clinical and Translational Radiation Oncology

    Article Title: Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator

    doi: 10.1016/j.ctro.2026.101200

    Figure Lengend Snippet: Longitudinal relative change in MR-Linac T2/FLAIR region of interest (ROI) volume from baseline (V rel , %) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines represent individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Article Snippet: For radiotherapy planning, all patients underwent MR simulation on a 1.5 T MRI scanner (Philips Ingenia) with gadolinium-enhanced T1-weighted, T2-weighted, diffusion-weight imaging (DWI), and fluid-attenuated inversion recovery (FLAIR) volumetric sequences.

    Techniques: Fractionation, Methylation

    Longitudinal migration distance (d migrate , mm) of MR-Linac T2/FLAIR region of interest (ROI) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines show individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Journal: Clinical and Translational Radiation Oncology

    Article Title: Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator

    doi: 10.1016/j.ctro.2026.101200

    Figure Lengend Snippet: Longitudinal migration distance (d migrate , mm) of MR-Linac T2/FLAIR region of interest (ROI) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines show individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Article Snippet: For radiotherapy planning, all patients underwent MR simulation on a 1.5 T MRI scanner (Philips Ingenia) with gadolinium-enhanced T1-weighted, T2-weighted, diffusion-weight imaging (DWI), and fluid-attenuated inversion recovery (FLAIR) volumetric sequences.

    Techniques: Migration, Fractionation, Methylation